Abstract
Recently, a variety of nanoparticles have been widely used as imaging agents or carriers for the diagnosis and therapy of lung cancer. However, their poor imaging effect, high toxicity, pro-inflammatory effect and ineffective treatment are still a great challenge. In this work, we reported a novel kind of BiOI@CuS nanoparticle to achieve safe and effective therapy of lung cancer by co-loading hydrochloric acid doxorubicin (DOX) and aspirin phenacetin and caffeine (APC). The nanoparticles can effectively relieve inflammatory reactions induced by photo-thermal therapy (PTT). In vitro and in vivo assays showed that DOX/APC co-loaded BiOI@CuS exhibited an effective chemo-photothermal comprehensive therapy effect and good CT imaging capability. Consequently, this multifunctional nanosystem provides a versatile and promising platform in the imaging and treatment of lung cancer in further applications.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
A549 Cells
-
Animals
-
Antibiotics, Antineoplastic / chemical synthesis
-
Antibiotics, Antineoplastic / chemistry
-
Antibiotics, Antineoplastic / pharmacology*
-
Aspirin / chemistry
-
Aspirin / pharmacology
-
Bismuth / chemistry
-
Caffeine / chemistry
-
Caffeine / pharmacology
-
Cell Proliferation / drug effects
-
Cell Survival / drug effects
-
Copper / chemistry
-
Doxorubicin / chemistry
-
Doxorubicin / pharmacology
-
Drug Screening Assays, Antitumor
-
Humans
-
Lung Neoplasms / diagnostic imaging
-
Lung Neoplasms / drug therapy*
-
Mice
-
Mice, Nude
-
Nanoparticles / chemistry*
-
Neoplasms, Experimental / diagnostic imaging
-
Neoplasms, Experimental / drug therapy
-
Particle Size
-
Phenacetin / chemistry
-
Phenacetin / pharmacology
-
Photochemotherapy*
-
Surface Properties
-
Tomography, X-Ray Computed*
-
Tumor Cells, Cultured
Substances
-
Antibiotics, Antineoplastic
-
Caffeine
-
Copper
-
Doxorubicin
-
Phenacetin
-
cupric sulfide
-
Aspirin
-
Bismuth